View as Webpage

Looking to develop a VZV vaccine? Let us help!

Our extensive catalog of viral antigens, kits, antibodies, and antibody titer detection kits for VZV Glycoprotein E as well as other virus antigens are all available!

What is Varicella-zoster Virus (VZV)?

Varicella-zoster virus is an extremely common virus that causes both chickenpox and shingles. VZV infection has an incidence rate of over 3 million cases per year in the US alone, with the virus remaining dormant within the body and reactivating years later as shingles, an uncomfortable, painful rash with blisters.

What options are available?

The only vaccines are indicated for adults over 50:

·       Merck – Zostavax using live-attenuated VZV.

·       GSK – Shingrix using recombinant glycoprotein E with AS01B adjuvant.

Explore ViruStop Now

Supporting your VZV Vaccine Development

From manufacturing to clinical research

Interested in learning about the impact of vaccines?

Read our article on how to improving HPV vaccines can lead to the elimination of cervical cancer. 

Learn about: 

·  Improving vaccine access

·  Key bottlenecks in vaccine development

·  Pseudoviruses to expand indications

Read more

To receive the latest industry news and updates from ACROBiosystems,

visit our website & follow us on our social media!

Visit our Website
LinkedIn  Twitter  YouTube  Facebook